[1]陈黎,陈枝俏.当飞利肝宁胶囊联合血脂康治疗合并高脂血症的非酒精性脂肪性肝病[J].中国中医药信息杂志,2007,14(2):64-65.
 [J].zhongguo zhongyiyao xinxi zazhi,2007,14(2):64-65.
点击复制

当飞利肝宁胶囊联合血脂康治疗合并高脂血症的非酒精性脂肪性肝病

参考文献/References:

[1] 中华医学会肝脏病学分会脂肪肝和酒精性肝病学组.非酒精性脂肪性肝病诊断标准[J].中华肝脏病杂志,2003,11(2):71.

[2] Brunt EM, Janney CG, Di Bisceglie AM, et al. Nonalcoholic steatohepatitis:a proposal for grading and staging the histologi- cal lesion[J].Am J Gastroenterol,1999,94:2467-2474.

[3] 中华心血管病杂志编辑委员会血脂异常防治对策专题组.血脂异常防治建议[J].中华心血管病杂志,1997,25(3):169-172.

[4] Yuan M, Konstantopoulos N, Lee J, et al. Reversal of obesity- and diet-induced insulin resistance with Salicylates or targeted disruption of Ikk[J].Science,2001,293:1673-1677.

[5] Solga SF, Diehl AM. Non-alcoholic fatty liver disease:lumen-liver interactions and possible role for probiotics[J]. Journal of Hepatology,2003,38:681-687.

[6] 刘 翎,谢贤春,吉中和,等.当飞利肝宁治疗实验性脂肪肝的研究[J].中国中药杂志,2003,28(8):787-789.

[7] Lindor KD, Kowdley KV, Heathcote EJ, et al. Ursodeoxycholic acid for treatment of nonalcoholic steatohepatitis:results of a randomized trial[J].Hepatology,2004,39(3):770-778.

相似文献/References:

[1]周凡,张宏久,闫小华,等.血脂康胶囊治疗高胆固醇血症的经济学评价[J].中国中医药信息杂志,2005,12(3):80.
 ZHOU Fan,ZHANG Hong-jiu,YAN Xiao-hua,et al.Application of Cost-Effectiveness Analysis in Xuezhikang and Pravastatin for the Treatment of Hypercholesterolemia[J].zhongguo zhongyiyao xinxi zazhi,2005,12(2):80.
[2]林 捷.消栓通络胶囊治疗脂肪肝32例[J].中国中医药信息杂志,2004,11(4):337.

更新日期/Last Update: